Globus Medical, Inc.
| Security | GMED / Globus Medical, Inc. |
| Insider | Ann D Rhoads |
This page shows the track record and history of RHOADS ANN D
insider trades in Globus Medical, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Ann D Rhoads in GMED / Globus Medical, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Ann D Rhoads in GMED / Globus Medical, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-13 | 15,000 | 70.3600 | 15,000 | 70.3600 | 1,055,400 | 311 | 51.8900 | -277,050 | -26.25 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-16 | 2025-09-15 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 58.4600 | -10,000 | -585 | 25,384 | ||||
| 2025-03-04 | 2025-02-28 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 78.6800 | -7,500 | -590 | 35,384 | ||||
| 2024-09-17 | 2024-09-13 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 70.3600 | -15,000 | -1,055 | 42,884 | ||||
| 2024-09-17 | 2024-09-13 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 25.5200 | 20,000 | 510 | 57,884 | ||||
| 2024-09-17 | 2024-09-13 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 24.1000 | 15,000 | 362 | 37,884 | ||||
| 2023-01-30 | 2023-01-27 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 12.5900 | 7,500 | 94 | 22,884 | ||||
| 2022-01-31 | 2022-01-27 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63.68 | 15,000 | 15,000 | |||||
| 2021-03-03 | 2021-03-01 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10.66 | -15,384 | 0 | |||||
| 2021-03-03 | 2021-03-01 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 10.6600 | 15,384 | 164 | 15,384 | ||||
| 2021-01-19 | 2021-01-14 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65.05 | 15,000 | 15,000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53.27 | 25,000 | 25,000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43.58 | 25,000 | 25,000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43.77 | 25,000 | 25,000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26.27 | 25,000 | 25,000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25.52 | 20,000 | 20,000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24.10 | 15,000 | 15,000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23.95 | 10,000 | 10,000 | |||||
| 2013-09-05 | 2013-01-30 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12.59 | 7,500 | 7,500 | |||||
| 2012-08-10 | 2012-08-08 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10.66 | 15,384 | 15,384 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
